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The fate of an intracellular pathogen in mononuclear phagocytes appears to be an 
important determinant of he capacity of the pathogen to cause disease. Antibody 
against the pathogen can markedly alter the intracellular fate of the pathogen in 
mononuclear phagocytes; uch an effect of antibody is reflected in vivo by enhanced 
resistance to infection of animals that have been passively immunized with hyperim- 
mune serum. Under these conditions, the specific immunity expressed by these 
animals results from the presence of antibody and not from the presence of antigen- 
sensitive leukocytes. For example, antibody inhibited the intracellular multiplication 
of the obligate intracellular parasite Rickettsia mooseri in cultured human monocytes 
and rendered the organism susceptible to killing by these monocytes (1); paralleling 
this in vivo, the same antibody protected passively immunized mice against an 
otherwise lethal infection from R. mooseri ([1]; and C. L. Wisseman, Jr. Personal 
communication.). Similarly, human and mouse antitoxoplasma antibody rendered 
the obligate intracellular parasite Toxoplasma gondii incapable of multiplying in 
cultured human monocytes (2) and mouse peritoneal macrophages (3), respectively; 
mouse anti-toxoplasma antibody protected passively immunized mice from lethal 
infection with T. gondii (4). 
With other intracellular pathogens, antibody does not significantly inhibit their 
multiplication in cultured leukocytes; this is reflected in vivo by a failure of antibody 
to protect passively immunized animals from infection. For example, immune mouse 
serum did not inhibit the multiplication of the facultative intracellular bacterium 
Listeria monocytogenes in cultured mouse peritoneal macrophages (5); and immune 
mouse serum did not protect mice from infection with L. monocytogenes (6). Similarly, 
antibody did not inhibit the multiplication of the facuhative intracellular bacterium 
Mycobacterium tuberculosis in cultured mouse, rabbit, or guinea pig peritoneal macro- 
phages (7-9); and immune mouse serum did not influence the survival of mice nor 
did immune guinea pig serum influence the course of infection in guinea pigs when 
these animals were challenged with M. tuberculosis (10, 11). In all these studies, there 
is a correlation between the capacity of antibody to inhibit intracellular infection of 
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mononuclear  phagocytes in vitro and to protect he passively immunized host against 
infection with the same pathogen, i.e., the in vitro studies appear  to accurately reflect 
the role of  ant ibody in host defense against diseases caused by intracel lular pathogens. 
Therefore, to define the role of  ant ibody in Legionnaires' disease, which is caused by 
the facultative intracel lular bacterial  pathogen Legionella pneumophila (12), we have 
studied the effect ofanti-L,  pneumophila ant ibody on host cell-L, pneumophila interaction. 
In the accompanying paper  (.13), we described our studies on the influence of 
ant ibody on the interaction of L. pneumophila with human serum and human poly- 
morphonuclear  leukocytes (PMN'). 1 We found that virulent egg yolk-grown L. pneu- 
mophila bacteria are completely resistant o the bactericidal effects of human serum 
whether or not the serum contains anti-L, pneurnophila ntibody. Moreover, we found 
that a significant proport ion (30-40%) of an inoculum of L. pneumophila is resistant to 
kil l ing by PMN even in the presence of  anti-L, pneumophila ant ibody and complement.  
In this paper,  we describe our studies on the effects of anti-L, pneumophila ant ibody 
on the interaction of L. pneumophila (Phi ladelphia 1 strain) with human monocytes. 
We demonstrate (a) that anti-L, pneumophila antibody, in the presence of complement,  
promotes the b inding of viable L. pneumophila to monocytes, as it does to PMN; (b) 
that monocytes, like PMN,  require both specific ant ibody and complement to kill any 
L pneumophila nd that,  under these conditions, monocytes kill only a l imited 
proport ion of a bacterial  inoculum; and (c) that L. pneumophila surviving the confron- 
tation with monocytes in the presence of specific ant ibody and complement mult ip ly 
in monocytes as rapid ly as when the bacter ia enter monocytes in the absence of  
specific ant ibody. 
Mater ia l s  and  Methods  
Media, Agar, Sera, and Bacteria. The media, agar, sera, and bacteria used in this study were 
obtained or prepared and stored as described in the accompanying paper (13). Normal human 
serum had an indirect fluorescent antibody (IFA) anti-L, pneumophila titer o f< 1:64 and immune 
human serum had an IFA anti-L, pneumophila titer of 1:4,096 (13). 
Human Blood Mononuclear Cells. The blood mononuclear cell fraction was obtained by 
centrifugation over a Ficoll-sodium diatrizoate solution as previously described (12); the cells 
were >99% viable by trypan blue exclusion. Examination of a stained cytocentrifuged sample 
revealed that the mononuclear cell fraction contained ~40% monocytes, 58.5% lymphocytes, 
and 1.5% PMN. The adherent subpopulation (containing >90% monocytes) and the nonad- 
herent subpopulation (containing >90% lymphocytes) were prepared as described (12). For use 
in the mononuclear cell-killing assay described below, adherent cells in Petri dishes were 
resuspended by incubating the cells for 10 min at 4°C (which causes most cells to round-up and 
many to detach) and gently scraping them off the bottom of the Petri dish with a rubber 
policeman. Recovered cells were 90% viable by trypan blue exclusion. 
Mononuclear Cell-killing Assay. This was identical to the PMN-killing assay described in the 
accompanying paper (13) except hat instead of PMN, 2 X 106 or 5 X 108 mononuclear cells, 
2 X 10 resuspended adherent mononuclear cells, or 2 X 106 nonadherent mononuclear cells 
were incubated with L. pneurnophila. At the end of the incubation, the contents of each tube 
were sonicated for 60 sec continuously with a micro-tip attached to a sonicator (Heat Systems- 
Ultrasonics, Inc., Plainview, N. Y.) with the output control of the sonicator set at the 4 position; 
this amount of sonic energy lysed the mononuclear cells completely but did not reduce bacterial 
colony-forming units (CFU) (12). 
Assay for the Binding of Viable L. pneumophila to Monocytes in the Presence or Absence of Anti-L. 
pneumophila Antibody. L. pneumophila (2.5 X 105 CFU/ml) were incubated in plastic test tubes 
I Abbreviations u ed in this paper: CFU, colony-forming units; IFA, indirect fluorescent a ibody assay; 
PMN, human polymorphonuclear leukocytes. 
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for 15 min at 37°C in 5.5 ml of medium that contained 30% fresh normal human serum or 30% 
fresh immune human serum. 1-ml quantities of these bacterial suspensions were then immedi- 
ately transferred to 35-ram Petri dishes containing freshly prepared monocyte monolayers in 1 
ml of RPMI-1640 medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, 
N. Y.) (~2 × 106 monocytes/Petri dish); the final vol in each Petri dish was 2 ml and the final 
serum concentration was 15%. Monocyte monolayers were incubated with bacteria for 1 h at 
37°C in 5% CO~-95% air on a gyratory shaker at 100 rpm. After the incubation, the monocyte 
monolayers were washed vigorously three times with RPMI-1640 (at 37°C) to remove non-cell- 
associated bacteria. Then 2 ml of RPMI-1640 was add6d to each Petri dish. The monocyte 
monolayers were then sonicated with a 2.54-cm-diam high-gain disrupter horn, attached to a 
sonieator (Heat Systems-Ultrasonics, Inc.) under sterile conditions with the output control of 
the sonicator set at the 4 position; this amount of sonic energy lysed the mononuclear cells 
completely but did not reduce bacterial CFU (12). CFU of L. pneumophila in each Petri dish 
were determined. Five Teplicate Petri dishes were used for each measurement. 
Infection of Mononuclear Cells in Suspension r Monocytes m a Monolayer in the Presence of Anti-L. 
pneumophila Antibody. In the experiment depicted in Fig. 2, L. pneumophila (5 × 104 CFU) were 
incubated at 37°C for 15 min in plastic test tubes in 750/.tl of medium that contained 250/~1 
of fresh normal human serum or 250 #1 of fresh immune human serum. Then 5 X 106 
mononuclear ceils (or RPMI-1640 as control) were added and the final vol in each tube was 
brought o 2.5 ml with RPMI-1640; the final serum concentration was 10%. A 100-/~1 sample 
from each tube was immediately removed and assayed for CFU of L. pneumophila on modified 
charcoal yeast extract agar as described (12). The tubes were then gassed to a pH of 7.4 with 
5% CO2-95% air, sealed, and incubated for 1 h at 37°C on a gyratory shaker at 250 rpm. 
Immediately after the incubation and at 24-h intervals for 4 d thereafter, the medium in each 
tube was assayed for CFU ofL. pneumophila. Five replicate ubes were used for each measurement. 
In the experiment depicted in Fig. 3, monocyte monolayers were infected in the presence of 
normal or immune serum exactly as in the assay for the binding of viable L. pneurnophila to
monocytes described above except hat the concentration f bacteria preincubated with 30% 
normal or 30% immune serum was 106 CFU/ml instead of 2.5 × 105 CFU/ml. After the 
monolayers were infected, Petri dishes were divided into two sets. Monocyte monolayers in the 
first set of Petri dishes (five that contained normal and five that contained immune serum) 
were washed vigorously three times with RPMI-1640 (at 37°C) to remove non-monocyte- 
associated bacteria nd the cells were reincubated in 2 ml RPMI-1640 and 15% serum of the 
same type to which they had initially been exposed~ The monolayers in two of these Petri 
dishes (one containing immune serum and in one containing normal serum) were then sonically 
disrupted, as in the binding assay, to determine the total number of CFU of L. pneumophila 
initially in these cultures. Monocyte monolayers in the second set of Petri dishes (four that 
contained immune and four that contained normal serum) were not washed free of non- 
monocyte associated bacteria. The remaining eight Petri dishes in the first set and the eight 
Petri dishes in the second set were incubated at 37°C in 5% CO2-95% air under stationary 
conditions. The medium in each Petri dish was assayed for CFU of L. pneumophila at the start 
of this incubation period and daily for 4 d thereafter. Four replicate Petri dishes were used for 
each measurement i  Fig. 3. 
Results  
Monocytes Require Both Specific Antibody and Complement toKill Any L. pneumophila. We 
incubated mononuclear cells with L. pneumophila in the presence of fresh normal 
human serum (a source of complement), heat-inactivated immune human serum (a  
source of anti-L, pneumophila ntibody), or fresh immune human serum (a source of 
both antibody and complement). Mononuclear cells killed L. pneumophila only when 
both a source of ant ibody and complement were present (Fig. 1 A). The mononuclear 
cells reduced CFU of L. pneumophila by only 0.25 log (45%). 
In separate xperiments, we incubated L. pneumophila with 2 × 106 lymphocytes 
(nonadherent mononuclear cells), 2 × 106 monoeytes (adherent mononuclear cells), or 
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Ftc. 1. Monocyte killing of L. pneumophila. (A) Mononuclear cells require both antibody and 
complement to kill any L. pneumophila. Mononuclear cells (5 × l0 n) were incubated with 2.5 X 105 
(2FU of L. pneumophila at 37°(2 in 5% CO2-95% air on a gyratory shaker for 1 h in medium that 
contained 10% fresh normal human serum (with an indirect fluorescent antibody assay (IFA) anti- 
L. pneumophila titer of <1:64), 10% fresh immune human serum (with an IFA anti-L, pneumophila 
titer of 1:4,096), or 10% heat-inactivated immune human serum (HI immune serum). (2FU were 
determined initially and at the end of the incubation. Each point represents he average for three 
replicate tubes 4- SE (B) Monocytes but not lymphocytes kill L. pneumophila. L. pneumophila (7.5 × 
6 6 10 s CFU) were incubated with 2 × 10 lymphocytes (nonadherent mononuclear cells), 2 × 10 
6 o monocytes (adherent mononuclear cells), or 2 × 10 mononuclear cells at 37 (2 in 5% (202-95% air 
on a gyratory shaker for 1 h in medium that contained 10% fresh immune human serum. Adherent 
and nonadherent mononuclear c ils were selected as described in Materials and Methods. (2FU 
were determined initially and at the end of the incubation. Each point represents he average for 
three replicate tubes 4- S.E. 
2 X 106 mononuclear cells in the presence of fresh immune human serum. Monocytes 
and mononuclear cells killed L. pneumophila (by 0.5 log and 0.25 log, respectively) but 
lymphocytes did not kill L. pneumophila (Fig. 1 B). This indicates that the monocytes 
in the mononuclear cell fraction are responsible for the killing. 
Thus, monocytes, like PMN, require both specific antibody and complement to kill 
any L. pneumophila; even then they kill only a limited proportion of a bacterial 
inoculum. 
Specific Antibody Promotes the Binding of Viable L. pneumophila to Monocytes. We 
preincubated L. pneumophila in medium that contained fresh normal or fresh immune 
human serum for 15 rain at 37°C and then further incubated the bacteria with 
monocyte monolayers for 1 h at 37°C as described in Materials and Methods. We 
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Fro. 2. Specific antibody fails to inhibit the multiplication of L. pneumophila in monocytes. L  
pneumophila (2.5 × 104 CFU) were incubated at 37°C for I0 min in 33% fresh normal human serum 
or 33% fresh immune human serum. The bacteria were then incubated at 37°C in 5% CO2-95% air 
with 5 × l0 s mononuclear cells (or RPMI-1640 as control) in medium that contained a final 
concentration f 10% of the same type of serum to which the bacteria were initially exposed. The 
cultures were shaken for 1 h and incubated under stationary conditions thereafter for 4 d. CFU 
were determined at 0, 1, 24, 48, 72, and 96 h after infecting the monocytes. Each point represents 
the average for five replicate tubes + SE. 
then sonicaUy disrupted the monolayers and assayed for CFU of L. pneumophila. 
Monocyte monolayers incubated with L. pneumophila in the presence of normal serum 
contained an average of 2,490 ___ 120 CFU of L. pneumophila ( verage for five replicate 
Petri dishes ± SE). Monocyte monolayers incubated with an equal number of L. 
pneumophila in the presence of immune serum contained an average of 8,290 + 440 
CFU of L. pneumophila, 3.3 times as many viable bacteria as when anti-L, pneumophila 
antibody was absent. Thus, specific antibody promotes the binding of viable L. 
pneumophila to monocytes as it does to PMN. 
Specific Antibody Does NotInhibit the Multiplication of L. pneumophila in Monocytes. We 
preincubated L. pneumophila in medium that contained fresh normal or fresh immune 
human serum for 15 rain at 37°C and then further incubated the bacteria with 
mononuclear cells for 4 d. During the 1st h of incubation with the mononuclear cells, 
the cultures were shaken on a gyratory shaker; thereafter they were incubated under 
stationary conditions. Serum of the same type to which the L. pneumophila were 
initially exposed was present hroughout. 
During the 1st h of incubation with mononuclear cells, the number of CFU of L, 
pneumophila in cultures that lacked specific antibody remained constant. However, 
CFU decreased 0.25 log in cultures that contained specific antibody (Fig. 2). This 
amount of killing was comparable to that observed in the experiments depicted in 
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FIo. 3. Monocyte-adherent bacteria coated with antibody and complement multiply in monocytes. 
L. pneumophila (106 CFU) were preincubated with fresh immune or fresh normal human serum for 
15 min at 37°C,.and further incubated for 1 h at 37°C on a gyratory shaker with monocyte 
monolayers in Petri dishes (~2 X 10 s monocytes/Petri dish) containing 2 ml RPMI-1640 and 15% 
of the same type of serum to which they were initially exposed. Some of the monocyte monolayers 
were then washed to remove nonmonocyte associated bacteria nd reincubated in 2 ml RPMI-1640 
and 15% serum of the same type to which they were initially exposed. The medium in each Petri 
dish was assayed aily for CFU of L. pneumophila. Points on the lines labeled "Adherent bacteria" 
(C) O) represent CFU of L. pneumophila in the medium of monocyte monolayer cultures that 
were washed to remove non-monocyte-associated bacteria. Separate measurements showed that, at 
the start of the final incubation (0 d after infection on this graph), 98 and 86% of the bacteria in 
these cultures incubated in the presence of immune and normal serum, respectively, were monocyte 
associated. Points on the lines labeled "Adherent and nonadherent bacteria" (0) represent CFU of 
L. pneumophila in the medium of monocyte monolayer cultures that were not washed to remove non- 
monocyte-associated bacteria. Each point represents he average for four replicate Petri dishes ± 
SE. 
Fig. 1. Subsequently, the number of CFU in cultures with and without specific 
antibody changed in parallel, first decreasing slightly and then increasing three logs. 
To confirm that monocyte-associated bacteria coated with antibody and comple- 
ment are capable of multiplying and initiating a cycle of infection in monocytes, and 
to study the growth kinetics of opsonized L. pneumophila in cultures that contained 
only monocytes, we did the following experiment. We preincubated L. pneumophila 
with fresh normal or fresh immune human serum for 15 min at 37°C, further 
incubated them with monocyte monolayers for 1 h, and washed some of the mono- 
layers to remove non-monocyte-associated bacteria, as described in Materials and 
Methods. To determine the total number of CFU of L. pneumophila present in cultures 
after the non-monocyte-associated bacteria had been washed away, we sonically 
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disrupted the monolayers in two Petri dishes and assayed for CFU. We further 
incubated the remaining cultures and assayed the culture medium of these cultures 
for CFU of L. pneumophila at the start of this incubation and daily for 4 d thereafter. 
Cultures that had been incubated for 1 h with L. pneumophila n the presence of 
fresh immune and fresh normal human serum contained 14,100 and 3,800 CFU/ml, 
respectively, after the cultures were sonically disrupted; a ratio of 3.7:1. This ratio is 
similar to the 3.3:1 ratio observed in the binding study discussed above. After washing 
away the bacteria, there were 300 CFU/ml in the medium of cultures that contained 
intact monolayers and immune serum (Fig. 3). Because there were 14,100 CFU/ml in 
a replicate culture containing a sonically disrupted monolayer, ~98% of the bacteria 
in the cultures containing intact monolayers and immune serum were monocyte- 
associated at the end of a 1-h incubation period, i.e., at the start (day 0) of the 
infection as shown in Fig. 3. 
L. pneumophila multiplied to high levels in cultures initially containing only adherent 
bacteria nd in cultures initially containing both adherent and nonadherent bacteria, 
whether or not antibody was present (Fig. 3). The rates of multiplication were similar 
in all cultures. We have obtained similar results in another experiment of this type in 
which we used ialyzed rabbit anti-L, pneumophila antiserum plus fresh normal human 
serum as the source of antibody and complement. In the accompanying paper, we 
showed that L. pneumophila ncubated for 15 min at 37°C in immune serum are coated 
with antibody and complement (13). Therefore, opsonized L. pneumophila b cteria 
bound to monocytes in the presence of antibody and complement are capable of 
multiplying and initiating a cycle of infection in monocytes and of doing so as rapidly 
as unopsonized bacteria. 
In all of these experiments, the peak level of L. pneumophila growth attained in 
cultures containing specific antibody was 0.25-0.5 log less than in cultures lacking 
specific antibody (Figs. 2 and 3). We do not know why this was so. 
Thus, when monocytes are incubated with L. pneumophila n the presence of specific 
antibody and complement, he leukocytes kill a small proportion of the bacteria; 
however, the surviving bacteria multiply in monocytes as rapidly as when the bacteria 
are not exposed to antibody. 
Discussion 
PMN and monocytes have similar requirements for killing L. pneumophila n that 
they require anti-L, pneumophila antibody and complement; antibody and complement 
increase the binding of viable bacteria to PMN and monocytes (5). In this respect, the 
interaction of PMN and monocytes with L. pneumophila resembles the interaction of 
these leukocytes with eficapsulated bacteria (14). However, whereas encapsulated 
Escherichia coli are highly susceptible to the bactericidal effects of phagocytic leukocytes 
(14), L. pneurnophila are relatively resistant to killing by PMN and monocytes. In their 
interaction with L. pneumophila, PMN and monoeytes differ from each other in that 
only monocytes support he intraeellular multiplication of L. pneumophila (12, 13). 
The experiments reported here and in the accompanying paper (13) show that 
antibody and complement fail to bring about two major biological effects, at least in 
vitro. First, they fail to promote effective killing of L. pneumophila by PMN and 
monocytes. Second, they fail to inhibit the growth of L. pneumophila n monocytes. 
Although our findings do not exclude a role for antibody and complement in 
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conjunction with cell-mediated immunity, they suggest hat humoral immunity by 
itself may not be an effective host defense against L. pneumophila; consequently, a 
vaccine that resulted only in antibody production against the Legionnaires' disease 
bacterium may not be efficacious. 
These results are consistent with our previous suggestion that cell-mediated im- 
munity plays an important role in host defense against L. pneumophila (4). 
Summary  
In an accompanying paper (13), we reported that human polymorphonuclear 
leukocytes kill only a limited proportion (0.5 log) of an inoculum of Legionella 
pneumophila (Philadelphia 1 strain) in the presence of human anti-L, pneumophila 
antibody and complement. We now report on the effect of anti-L, pneumophila antibody 
on L. pneumophila-monocyte in raction. The studies were carried out under antibiotic- 
free conditions. 
Monocytes bind more than three times as many viable L. pneumophila bacteria in 
the presence of both antibody and complement than in the presence of complement 
alone. Monocytes require both antibody and complement to kill any L. pneumophila: 
however, even then, monocytes kill only a limited proportion (0.25 log) of an 
inoculum. The surviving bacteria multiply several logs in the monocytes and multiply 
as rapidly as when the bacteria enter monocytes in the absence of antibody. 
These findings suggest that humoral immunity may not be an effective host defense 
against L. pneumophila. Consequently, a vaccine that resulted only in antibody pro- 
duction against he Legionnaires' disease bacterium may not be efficacious. 
We thank Ms. Darragh Kelvie for excellent echnical assistance. 
Received for publication 16 October 1980. 
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